Condition : Osteoarthritis, Knee Interventions : Drug: LY2828360; Drug: Placebo Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Conditions : Sjogren's Syndrome; Xerostomia Intervention : Drug: Dexamethasone Sponsor : National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting - verified January 2011

Condition : Spondylarthropathies; Spondylitis, Ankylosing Interventions : Drug: etoricoxib; Drug: Other COX-2 inhibitor; Drug: nsNSAIDs Sponsors : Merck; Merck; Lund University Active, not recruiting...

Condition : Spondylarthropathies; Spondylitis, Ankylosing Interventions : Drug: etoricoxib; Drug: Other COX-2 inhibitor; Drug: nsNSAIDs Sponsors : Merck; Lund University Active, not recruiting - verif...

Participants in a primary care clinic or office with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis for whom the treatment with Simponi® by autoinjector device is to be initiated...

Participants in a primary care clinic or office with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis for whom the treatment with Simponi® by autoinjector device is to be initiated...

This study is designed to evaluate the effectiveness of adding Etanercept to disease modifying anti-rheumatic drug (DMARD) therapy in subjects with moderately active Rheumatoid Arthritis (RA).

This study is designed to evaluate the effectiveness of adding Etanercept to disease modifying anti-rheumatic drug (DMARD) therapy in subjects with moderately active Rheumatoid Arthritis (RA).

Participants in a primary care clinic or office with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis for whom the treatment with Simponi® by autoinjector device is to be initiated...

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Completed - verified November 2013